유럽 연합 - 에스토니아어 - EMA (European Medicines Agency)

viiv healthcare b.v. - cabotegravir - hiv-nakkused - viirusevastased ravimid süsteemseks kasutamiseks - apretude is indicated in combination with safer sex practices for pre-exposure prophylaxis (prep) to reduce the risk of sexually acquired hiv-1 infection in high-risk adults and adolescents, weighing at least 35 kg (see sections 4. 2, 4. 4 ja 5.